Aqualyx® – Advanced Injectable Lipolytic Solution (Italy)

Aqualyx® is a clinically proven, injectable lipolytic formulation developed and manufactured in Italy by Marllor Biomedical SRL. It is specifically designed for targeted fat reduction through intralipotherapy, offering aesthetic professionals a reliable solution for treating localized adipose deposits resistant to diet and exercise.

Formulated with sodium deoxycholate, a bile salt naturally produced by the human body, Aqualyx® works by selectively breaking down adipocytes in stubborn fat areas. Its biocompatible composition ensures high safety, excellent tolerability, and predictable clinical outcomes when administered by trained professionals.

Key Clinical Benefits

• Effectively targets localized fat deposits (“fat traps”)

• Ideal for areas such as abdomen, flanks, thighs, hips, arms, and knees

• Non-surgical alternative to traditional liposuction

• Based on physiological bile salts, minimizing systemic risk

• Proven efficacy through intralipotherapy protocols

Treatment Scope & Indications

Aqualyx® is best suited for body contouring applications where fat thickness is sufficient for optimal response. While facial use is limited, it may be considered in selected cases such as submental fat (double chin), provided the adipose layer is ≥1.5 cm. For delicate facial areas, lighter mesolipolytic solutions are generally recommended.

Why Choose Aqualyx® for Your Clinic

• Italian-manufactured with European quality standards

• Trusted by aesthetic practitioners worldwide

• Enhances clinic offerings with high-demand, non-invasive fat reduction treatments

• Delivers visible, long-lasting results with proper patient selection

For professional use only.
Aqualyx® should be administered exclusively by trained and licensed medical practitioners.